But the nature of side effects differs significantly, with tirzepatide causing primarily transient gastrointestinal symptoms versus Qsymia's potential for sustained cardiovascular and neurological effects requiring ongoing monitoring
Consequently, a change in GSH or GSSG can arise from altered substrate availability or enzyme activity even when ROS production is unchanged
In the UK right now, access is still limited, supply is fragile, and NHS use is tightly targeted
For instance, research from Mintel found that 90% of GLP-1 users still purchase ice cream a figure thats actually higher than the general population
Despite barriers, GLP-1 coverage seen as an attractive and desired benefit Most HR decision-makers are open to adding GLP-1 medications to their benefits package 81% feel their employees are interested
Lu S, Yin H, Yu OHY, Azoulay L